Coronavirus (COVID-19) measures at OUI

The situation regarding the Coronavirus (Covid-19) in the UK and the rest of the world continues to evolve, and our response to it is being constantly reviewed by OUI Management. We are primarily responding to guidance from the UK Government and the University of Oxford.

OUI’s continuing support to the University community is explained in a letter from Matt Perkins here (pdf, 172kb), which is also reproduced in full below.

This page will be updated as and when new information is available. It was last updated on Friday 3rd April 2020.

Message from OUI's CEO to University Colleagues

Dear Colleagues,

During these uncertain times as everyone adjusts to the coronavirus situation, I’d like to you know that OUI is still available, working to support and offer services to you, the University community of students, researchers and support staff.

Everyone will be adapting to new working practices and new ways of communicating without face to face interaction. Fortunately for us, many of our patenting, licensing and contract processes are already conducted online or by phone.

All of our OUI staff are working from home, and we are all contactable via phone and email. We’re using various other online platforms for meetings, so just let us know what you prefer, and our incubator is live streaming their training sessions. More resources like this will become available as we adapt to new ways of working remotely.

Many university departments host regular OUI hotdesks, and in place of these OUI staff will be available for virtual “drop in” appointments. All staff, students and researchers are welcome to use these resources and no question is too small or project too early! Details about this are being send to departments that host hotdesks.

There are various ways in which OUI has already been working with researchers to support and facilitate projects related to COVID-19. The question of how to get these out to the community to help save lives quickly in the short term whilst preserving an appropriate commercial position for the medium to long term is now under review.  OUI is working with Research Services to put together some principles on how we should address this in our licensing terms and we would welcome any suggestions from you for consideration. Example of projects that OUI are involved with include:

  • Professor Sarah Gilbert’s vaccine programme (https://www.theguardian.com/society/2020/mar/19/uk-drive-develop-coronavirus-vaccine-science) where we have protected the IP and are supporting discussions with potential commercial partners to ensure the vaccine can progress as quickly as possible through preclinical and clinical testing, can be produced at the scale needed for global supply, and can be delivered to all parts of the world affected by coronavirus.
  • Expedited approval by the UCSF (an OUI run translational fund) of a new drug discovery programme aimed at coronavirus.
  • Working with Professors Cui and Huang to support a new rapid diagnostic test for COVID-19 co-developed by the IBME and OSCAR, where OUI is supporting the commercialisation via a suitable licensing route.
  • Working with academics from the departments of Engineering and Primary Care, plus commercial partners, to implement remote blood pressure monitoring for pregnant women and avoid unnecessary potential exposure to coronavirus.
  • OUI also runs the University Challenge Seed Fund (“UCSF”) a translational fund, and projects submitted that are COVID-19 related will be fast-tracked. It is open to all Divisions and Departments who wish to apply for translational funding. For advice please contact your department’s OUI Licensing and Venture Manager in the first instance. For any follow up questions please contact either Jaz Jandor or Adam Workman.

For further information on COVID-19 related funding calls for researchers and companies see https://researchsupport.admin.ox.ac.uk/funding/covid-19

In the meantime, everyone at OUI hopes that you, your colleagues and families are well and stay healthy.

 

Best wishes

Dr Matt Perkins

CEO, Oxford University Innovation

^ Back to top

What do I need to know if I wish to visit OUI's office in Oxford?

Visitors are not permitted in the OUI office until further notice. This includes University members, incubatees and non-University visitors.

If you have a meeting already planned, your OUI contact will contact you to confirm this and to seek to rearrange the meeting as a video or audio call.

OUI staff contact details are here. If you do not know who to contact please use the contact form on this website.

^ Back to top

What measures are being taken by OUI?

All OUI staff are working from home until further notice.

OUI is actively supporting staff to utilise technology and tools that allow contact with our business partners to continue regardless of physical proximity. Our business operations continue as usual.

Regular internal communications ensure that our staff are vigilant and taking necessary precautions.

^ Back to top

Where can I find status updates from the University of Oxford?

Comprehensive guidance from the University is published and regularly updated here.

If you have contact with the University as well as OUI, please refer to this.

^ Back to top

© Oxford University Innovation